Currently the Enterprise Value (EV) is not available for Standard BioTools.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 5.7,
with a Debt / Equity ratio of 0.07.
5.7
5.09
0.07
-0.28
-0.22
-52.85
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$283.63K
$-225.83K
615
0.28
2.21
Taxes
573K
-0.41%
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.14, so Standard BioTools's
price volatility has been higher than the market average.
1.14
n/a
3.56
n/a
50.89
956,988
Income Statement
In the last 12 months, Standard BioTools had revenue of 174.43M
and earned -138.88M
in profits. Earnings per share was -0.52.